Annual SG&A:
$163.48M+$17.39M(+11.90%)Summary
- As of today, XERS annual SG&A is $163.48 million, with the most recent change of +$17.39 million (+11.90%) on December 31, 2024.
- During the last 3 years, XERS annual SG&A has risen by +$37.76 million (+30.04%).
- XERS annual SG&A is now at all-time high.
Performance
XERS SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly SG&A:
$44.39M+$375.00K(+0.85%)Summary
- As of today, XERS quarterly SG&A is $44.39 million, with the most recent change of +$375.00 thousand (+0.85%) on June 30, 2025.
- Over the past year, XERS quarterly SG&A has increased by +$4.40 million (+11.00%).
- XERS quarterly SG&A is now -18.06% below its all-time high of $54.18 million, reached on December 31, 2021.
Performance
XERS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SG&A:
-$2.70B-$32.00M(-1.20%)Summary
- As of today, XERS TTM SG&A is -$2.70 billion, with the most recent change of -$32.00 million (-1.20%) on June 30, 2025.
- Over the past year, XERS TTM SG&A has dropped by -$2.86 billion (-1863.84%).
- XERS TTM SG&A is now -4361.00% below its all-time high of -$60.59 million.
Performance
XERS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, General & Administrative Expenses Formula
SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development
XERS Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +11.9% | +11.0% | -1863.8% |
| 3Y3 Years | +30.0% | +34.6% | -1906.5% |
| 5Y5 Years | +159.2% | +151.6% | -3638.7% |
XERS Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +30.0% | -1.3% | +32.1% | -34.1% | at low |
| 5Y | 5-Year | at high | +159.2% | -18.1% | +169.3% | -137.8% | at low |
| All-Time | All-Time | at high | +3926.6% | -18.1% | +3210.4% | -4361.0% | at low |
XERS Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $44.39M(+0.9%) | $173.52M(+2.6%) |
| Mar 2025 | - | $44.02M(+9.7%) | $169.12M(+3.4%) |
| Dec 2024 | $163.48M(+11.9%) | $40.14M(-10.7%) | $163.48M(+1.6%) |
| Sep 2024 | - | $44.97M(+12.4%) | $160.91M(+5.0%) |
| Jun 2024 | - | $39.99M(+4.2%) | $153.23M(+1.6%) |
| Mar 2024 | - | $38.38M(+2.2%) | $150.87M(+3.3%) |
| Dec 2023 | $146.09M(+6.1%) | $37.57M(+0.8%) | $146.09M(+2.2%) |
| Sep 2023 | - | $37.29M(-0.9%) | $142.88M(+2.0%) |
| Jun 2023 | - | $37.63M(+12.0%) | $140.09M(+3.4%) |
| Mar 2023 | - | $33.60M(-2.2%) | $135.44M(-1.7%) |
| Dec 2022 | $137.75M(+9.6%) | $34.36M(-0.4%) | $137.75M(-12.6%) |
| Sep 2022 | - | $34.49M(+4.6%) | $157.57M(+5.3%) |
| Jun 2022 | - | $32.98M(-8.2%) | $149.61M(+5.0%) |
| Mar 2022 | - | $35.91M(-33.7%) | $142.55M(+13.4%) |
| Dec 2021 | $125.72M | $54.18M(+104.2%) | $125.72M(+40.4%) |
| Sep 2021 | - | $26.54M(+2.3%) | $89.54M(+12.6%) |
| Jun 2021 | - | $25.93M(+35.9%) | $79.49M(+11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $19.08M(+6.0%) | $71.20M(-3.4%) |
| Dec 2020 | $73.73M(+16.9%) | $18.00M(+9.2%) | $73.73M(-3.5%) |
| Sep 2020 | - | $16.48M(-6.6%) | $76.38M(+2.1%) |
| Jun 2020 | - | $17.64M(-18.3%) | $74.77M(+3.6%) |
| Mar 2020 | - | $21.61M(+4.7%) | $72.15M(+14.4%) |
| Dec 2019 | $63.06M(+198.7%) | $20.64M(+38.8%) | $63.06M(+23.3%) |
| Sep 2019 | - | $14.88M(-1.0%) | $51.14M(+25.0%) |
| Jun 2019 | - | $15.02M(+20.0%) | $40.92M(+34.6%) |
| Mar 2019 | - | $12.52M(+43.5%) | $30.39M(+43.9%) |
| Dec 2018 | $21.11M(+163.4%) | $8.72M(+87.6%) | $21.11M(+36.3%) |
| Sep 2018 | - | $4.65M(+3.4%) | $15.49M(+20.5%) |
| Jun 2018 | - | $4.50M(+38.9%) | $12.85M(+53.9%) |
| Mar 2018 | - | $3.24M(+4.6%) | $8.35M(+29.4%) |
| Dec 2017 | $8.02M(+97.4%) | $3.10M(+53.6%) | $6.46M(+92.3%) |
| Sep 2017 | - | $2.02M(+50.4%) | $3.36M(+150.4%) |
| Mar 2017 | - | $1.34M | $1.34M |
| Dec 2016 | $4.06M | - | - |
FAQ
- What is Xeris Biopharma Holdings, Inc. annual SG&A?
- What is the all-time high annual SG&A for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. annual SG&A year-on-year change?
- What is Xeris Biopharma Holdings, Inc. quarterly SG&A?
- What is the all-time high quarterly SG&A for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. quarterly SG&A year-on-year change?
- What is Xeris Biopharma Holdings, Inc. TTM SG&A?
- What is the all-time high TTM SG&A for Xeris Biopharma Holdings, Inc.?
- What is Xeris Biopharma Holdings, Inc. TTM SG&A year-on-year change?
What is Xeris Biopharma Holdings, Inc. annual SG&A?
The current annual SG&A of XERS is $163.48M
What is the all-time high annual SG&A for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high annual SG&A is $163.48M
What is Xeris Biopharma Holdings, Inc. annual SG&A year-on-year change?
Over the past year, XERS annual SG&A has changed by +$17.39M (+11.90%)
What is Xeris Biopharma Holdings, Inc. quarterly SG&A?
The current quarterly SG&A of XERS is $44.39M
What is the all-time high quarterly SG&A for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high quarterly SG&A is $54.18M
What is Xeris Biopharma Holdings, Inc. quarterly SG&A year-on-year change?
Over the past year, XERS quarterly SG&A has changed by +$4.40M (+11.00%)
What is Xeris Biopharma Holdings, Inc. TTM SG&A?
The current TTM SG&A of XERS is -$2.70B
What is the all-time high TTM SG&A for Xeris Biopharma Holdings, Inc.?
Xeris Biopharma Holdings, Inc. all-time high TTM SG&A is -$60.59M
What is Xeris Biopharma Holdings, Inc. TTM SG&A year-on-year change?
Over the past year, XERS TTM SG&A has changed by -$2.86B (-1863.84%)